NJBIZ

FDA issues EUA for GenScript’s test detecting neutralizing antibodies from COVID-19

Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
BioWorld

Items Tagged with 'Cpass'

The U.S. FDA has granted emergency use authorization (EUA) to Genscript USA Inc. for its Cpass SARS-CoV-2 Neutralization Antibody Detection Kit, the first commercially available test to detect ...
Labroots

Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript's SARS-CoV-2 Surrogate Virus Neutralization (sVNT) Test

SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports the ...
Business Insider

Todos Medical Completes Validation of cPass Neutralizing Antibody Blood Test at Provista Diagnostics to Quantify and Monitor Key Biomarkers of COVID-19 Immunity

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Todos Medical NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Business Insider

Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Todos Medical NewsMORE Related Stocks Indices Commodities Currencies Stocks ...